Holding(s) in Company | 16-Aug-2023 | 18:00 | RNS |
Holding(s) in Company | 11-Aug-2023 | 16:17 | RNS |
Result of General Meeting | 08-Aug-2023 | 17:18 | RNS |
Result of Conditional Fundraise | 19-Jul-2023 | 18:16 | RNS |
Proposed Fundraise in excess of £2 million | 19-Jul-2023 | 12:31 | RNS |
Positive final data in preclinical efficacy study | 17-Jul-2023 | 07:00 | RNS |
Positive interim data | 19-Jun-2023 | 07:00 | RNS |
BiVictriX nominates clinical candidate for BVX001 | 06-Jun-2023 | 07:00 | RNS |
Result of Annual General Meeting | 04-May-2023 | 16:36 | RNS |
Publication of Annual Report and Notice of AGM | 31-Mar-2023 | 07:00 | RNS |
BiVictriX Full Year Results | 30-Mar-2023 | 07:00 | RNS |
Appointment of Alex Hughes as CFO | 01-Mar-2023 | 07:01 | RNS |
BiVictriX reports positive BVX001 preclinical data | 31-Jan-2023 | 07:08 | RNS |
Holding(s) in Company | 24-Jan-2023 | 16:21 | RNS |
Holding(s) in Company | 19-Jan-2023 | 11:00 | RNS |
Currency | UK Pounds |
Share Price | 11.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 15.90 |
52 Week Low | 10.50 |
Volume | 0 |
Shares Issued | 82.53m |
Market Cap | £9.49m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
You are here: research